首页|围手术期静脉泵注艾司氯胺酮对妇科腹腔镜手术患者术后胃肠功能的影响

围手术期静脉泵注艾司氯胺酮对妇科腹腔镜手术患者术后胃肠功能的影响

扫码查看
目的 观察不同剂量艾司氯胺酮对妇科腹腔镜手术患者术后胃肠道功能的影响。方法 选择全麻下行腹腔镜子宫切除术或子宫平滑肌瘤剔除术患者90例,采用随机数字表法将所有患者随机分为3组:对照组(C组)、0。25 mg/(kg·h)艾司氯胺酮组(S1组)和0。50 mg/(kg·h)艾司氯胺酮组(S2组)。于麻醉诱导前10 min,S1组和S2组患者分别静脉泵注0。25 mg/(kg·h)或0。50 mg/(kg·h)的艾司氯胺酮至手术结束前30 min,C组患者给予等量生理盐水,3组患者其他麻醉方案一致。于气腹前、气腹中1 h和气腹结束后1 h采集外周静脉血,采用酶联免疫吸附试验检测血清人肠型脂肪酸结合蛋白(I-FABP)和闭合蛋白-1质量浓度,记录患者心率、平均动脉压变化,随访术后患者首次排气时间、首次排便时间,72 h内患者胃肠道症状评定量表评分及术后不良反应发生情况。结果 与气腹前相比,C组、S1组和S2组患者气腹中1 h时血清I-FABP质量浓度均升高(P<0。05),S2 组患者气腹结束后1 h时血清I-FABP质量浓度低于C组患者(P<0。05)。与气腹前相比,S2组患者气腹中1 h及气腹结束后1 h时血清闭合蛋白-1质量浓度升高(P<0。05),并高于C组患者(P<0。05)。与C组患者相比,S1组、S2组患者术中瑞芬太尼和丙泊酚用量减少(P<0。05),S2组患者使用血管活性药频次明显减少(P<0。05)。3组患者术后72 h内胃肠道症状评定量表评分、首次排气时间、首次排便时间、头晕、噩梦的不良反应发生情况差异无统计学意义(P>0。05)。结论 妇科腹腔镜手术会影响肠屏障功能,围手术期静脉泵注艾司氯胺酮能够增加血清闭合蛋白-1质量浓度,并使血清中I-FABP质量浓度降低,与增加肠屏障稳定性具有相关性,促进胃肠功能恢复。围手术期使用艾司氯胺酮不增加患者72 h内胃肠道症状评定量表评分和首次排气时间、首次排便时间。
Effect of esketamine on postoperative gastrointestinal function in patients after gynecological laparoscopic surgery
Objective To observe the effects of different doses of esketamine on postoperative gastrointestinal function in patients after gynecologic laparoscopic surgery.Methods 90 patients were selected to undergo laparoscopic hysterectomy or uterine smooth muscle tumor removal under general anesthesia,and all patients were randomly divided into three groups:the control group(group C),the 0.25 mg/(kg·h)esketamine group and the 0.50 mg/(kg·h)esketamine group(group S2).Different doses of esketamine were injected(group S1 intravenically from 10.0 min before anesthesia induction to 30.0 min before the end of surgery,and the control group was given the same amount of normal saline.Other anesthesia regimens were consistent among the 3 groups.Venous blood was collected to detect intestinal fatty acid-binding proteinlm(I-FABP)and Claudin-1 protein concentrations,the changes of patients'heart rate and mean arterial pressure were recorded,the time of patients'first exhaust defecation after surgery,I-FEED score within 72 h and the occurrence of postoperative adverse reactions were followed up.Results Compared with that before pneumoperitoneum,the serum I-FABP concentration in groups C,S1 and S2 was increased at 1 h after pneumoperitoneum(P<0.05),and the serum I-FABP concentration in group S2 lower than that in group C at 1 h after pneumoperitoneum(P<0.05).Compared with that before pneumoperitoneum,the serum Claudin-1 protein concentration in group S2 was increased at 1 h after pneumoperitoneum and 1 h after the end of pneumoperitoneum(P<0.05),and higher than that in group C(P<0.05).Compared with group C,the intraoperative dosage of remifentanil and propofol in group S1 was decreased(P<0.05),and the frequency of vasoactive drugs in group S2 was signifi-cantly decreased(P<0.05).Comparison of the occurrence of adverse reactions of I-FEED score,the time of first gas and bowel movement,dizziness,and nightmare in the three groups within 72 h after surgery showed no statistically significant difference(P>0.05).Conclusion Gynecological laparoscopic surgery can affect the intestinal barrier function.Perioperative intravenous injection of esketamine can up-regulate the expression of Clau din-1 protein and reduce the serum I-FABP content,which correlates with increased intestinal barrier stability,thereby promoting recovery of the gastrointestinal function.In addition,perioperative use of esket-amine may not increase patients'I-FEED score and time to first exhaust bowel movement within 72 hours.

esketamineintestinal barriertight junctionuterine leiomyomageneral anesthesiagastrointesti nal function

张丽、王迎斌、刘艳、曹璐、张伟

展开 >

兰州大学 第二临床医学院,甘肃 兰州 730030

兰州大学第二医院 麻醉科,甘肃 兰州 730030

艾司氯胺酮 肠屏障 紧密连接 子宫肌瘤 全身麻醉 胃肠道功能

兰州大学第二医院"萃英科技创新"计划

CY2022-MS-A20

2024

兰州大学学报(医学版)
兰州大学

兰州大学学报(医学版)

CSTPCD
影响因子:0.641
ISSN:1000-2812
年,卷(期):2024.50(2)
  • 25